Johnson & Johnson Stock Quote & Summary Data
Dynamic quotes: Off
|
ETFs with JNJ as a Top 10 Holding*Sponsored by:
| Weighting | ETF Name (Symbol) | 100-Day Price Change (%) |
|---|---|---|
| 12.79% | Select Sector SPDR Fund - Health Care (XLV) | +8.71 (21.75%) |
| 11.76% | iShares Dow Jones U.S. Health Care Index Fund (IYH) | +18.52 (22.09%) |
| 11.7% | Merrill Lynch Pharmaceutical HOLDRS (PPH) | +7.07 (17.74%) |
| 10.56% | Vanguard Health Care ETF (VHT) | +15.92 (22.13%) |
| 9.94% | iShares Dow Jones U.S. Pharmaceutical Index Fund (IHE) | +15.88 (18.58%) |
|
||
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Johnson & Johnson and its subsidiaries (the "Company") have approximately 127,600 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. Johnson & Johnson is a holding company, which has more than 275 operating companies conducting business in virtually all countries of the world. The Company’s primary focus has been on products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887. The Company’s structure is based on the principle of decentralized management. The Executive Committee of Johnson & Johnson is the principal management group responsible for the strategic operations and allocation of the resources of the Company. This Committee oversees and coordinates the activities of the Consumer, Pharmaceutical and Medical Devices and Diagnostics business segments. ... More ...
Consensus Recommendation |
|
Analyst Info |
|
| Annual EPS Est: | $5.1 |
| Quarterly EPS Est: | 1.4 |
| PEG Ratio: | 2.62 |
|
Mean Recommendation: View Summary / View All |
1.95 |
Data is provided by Zacks Investment Research